Innovative drug firms to face certification revocation

Last year, the government selected 43 companies as innovative pharmaceutical firms. Those in the category receive various benefits, including priority to participate in state-run research and development projects, tax redemption, as well as financial support for building research labs.

Some of these drug makers, who have been involved in offering kickbacks to hospitals and clinics, may lose ...